Significance of BCS classification MCQs With Answer

Introduction: The Biopharmaceutics Classification System (BCS) is a cornerstone concept for B. Pharm students, linking drug solubility, permeability, dissolution, and drug absorption to predict oral bioavailability and guide formulation strategies. Understanding BCS classification, dose number, solubility testing, permeability assays (e.g., Caco-2, PAMPA), and regulatory biowaiver criteria equips students to evaluate drug development, generic approval paths, and IVIVC considerations. Mastery of BCS helps in selecting salt forms, solid dispersions, permeability enhancers, and designing dissolution tests that impact bioavailability and therapeutic outcomes. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. What is the primary purpose of the Biopharmaceutics Classification System (BCS)?

  • To classify drugs by therapeutic class and dosing frequency
  • To categorize drugs by solubility and permeability to predict absorption
  • To rank drugs by market sales and patent status
  • To identify drug stability under various storage conditions

Correct Answer: To categorize drugs by solubility and permeability to predict absorption

Q2. Which of the following correctly describes a BCS Class II drug?

  • High solubility, high permeability
  • Low solubility, high permeability
  • High solubility, low permeability
  • Low solubility, low permeability

Correct Answer: Low solubility, high permeability

Q3. According to common regulatory definitions, a drug is considered “highly soluble” when:

  • It is soluble in water at any temperature
  • The highest marketed single dose is soluble in 250 mL across pH 1–7.5 at 37°C
  • It dissolves completely in 1 L of water
  • It has a log P value greater than 3

Correct Answer: The highest marketed single dose is soluble in 250 mL across pH 1–7.5 at 37°C

Q4. “High permeability” in BCS is commonly defined based on:

  • In vitro solubility in simulated gastric fluid
  • Extent of absorption in humans (commonly ≥85% absorbed)
  • Permeability measured only by PAMPA regardless of in vivo data
  • Molecular weight below 300 Da

Correct Answer: Extent of absorption in humans (commonly ≥85% absorbed)

Q5. The dose number (Do) is used in BCS to relate dose to solubility. Which formula represents Do?

  • Do = (Solubility × Volume) / Dose
  • Do = Dose / (Solubility × 250 mL)
  • Do = Dose × Solubility
  • Do = log(Dose) / log(Solubility)

Correct Answer: Do = Dose / (Solubility × 250 mL)

Q6. Which experimental method is commonly used to measure intrinsic aqueous solubility of a drug substance?

  • Caco-2 permeability assay
  • Shake-flask solubility method with HPLC analysis
  • Mass spectrometry of plasma samples
  • PAMPA permeability test

Correct Answer: Shake-flask solubility method with HPLC analysis

Q7. Which in vitro model is a cell-based system widely used to estimate intestinal permeability?

  • Shake-flask method
  • Caco-2 cell monolayer assay
  • PAMPA without cells
  • Dissolution apparatus II

Correct Answer: Caco-2 cell monolayer assay

Q8. For BCS-based biowaivers, regulatory agencies most commonly allow waivers for which class of drugs?

  • Class IV only
  • Class I and certain Class III under strict conditions
  • Class II only
  • All classes without restrictions

Correct Answer: Class I and certain Class III under strict conditions

Q9. Which BCS class is typically described as “permeability-limited absorption” where solubility is good?

  • Class I
  • Class II
  • Class III
  • Class IV

Correct Answer: Class III

Q10. What is a common formulation strategy for a BCS Class II drug to improve oral absorption?

  • Use of permeability enhancers only
  • Solubility enhancement techniques like micronization, solid dispersions, or cyclodextrins
  • Reducing dose without changing formulation
  • Adding sustained-release excipients to slow dissolution

Correct Answer: Solubility enhancement techniques like micronization, solid dispersions, or cyclodextrins

Q11. Which factor can make permeability assessment by Caco-2 cells underestimate in vivo absorption?

  • Absence of transporters and efflux pumps in Caco-2 cells
  • Overexpression of efflux transporters (e.g., P-gp) in the cell model
  • Use of 250 mL as dissolution volume
  • High drug solubility in buffer

Correct Answer: Overexpression of efflux transporters (e.g., P-gp) in the cell model

Q12. How does drug pKa influence BCS-related solubility?

  • pKa determines permeability but not solubility
  • Ionic state (ionized vs unionized) across gastrointestinal pH alters apparent solubility
  • pKa only affects taste, not dissolution
  • pKa always increases solubility irrespective of pH

Correct Answer: Ionic state (ionized vs unionized) across gastrointestinal pH alters apparent solubility

Q13. Which statement correctly contrasts BCS Class I and Class IV drugs?

  • Class I: low solubility, high permeability; Class IV: high solubility, low permeability
  • Class I: high solubility & permeability; Class IV: low solubility & permeability
  • Class I: demands advanced formulation; Class IV: no special formulation needed
  • Class I and IV have identical absorption behavior

Correct Answer: Class I: high solubility & permeability; Class IV: low solubility & permeability

Q14. Which in vitro dissolution specification is commonly considered sufficient to support a biowaiver for immediate-release Class I drugs?

  • Very slow dissolution in only one medium
  • Rapid dissolution (commonly ≥85% in 30 minutes) in relevant media
  • No dissolution testing required at all
  • Dissolution less than 50% in 60 minutes

Correct Answer: Rapid dissolution (commonly ≥85% in 30 minutes) in relevant media

Q15. What does IVIVC stand for and why is it relevant to BCS?

  • In Vitro–In Vivo Correlation; it links dissolution behavior to oral absorption and supports formulation decisions
  • In Vivo–In Vitro Calculation; it measures plasma protein binding
  • Internal Validation of In Vitro Cells; used only in toxicity testing
  • Instant Variation in In Vivo Clearance; used for hepatic metabolism studies

Correct Answer: In Vitro–In Vivo Correlation; it links dissolution behavior to oral absorption and supports formulation decisions

Q16. The Biopharmaceutics Drug Disposition Classification System (BDDCS) differs from BCS mainly by classifying drugs based on:

  • Only solubility and pH-solubility profile
  • Extent of metabolism and solubility rather than permeability alone
  • Color and taste of the drug product
  • Manufacturing cost and patent expiry

Correct Answer: Extent of metabolism and solubility rather than permeability alone

Q17. Which analytical consideration is essential when performing shake-flask solubility studies for BCS classification?

  • Maintain non-sink conditions intentionally
  • Ensure equilibrium is reached and use validated analytical quantification (e.g., HPLC)
  • Use only distilled water at room temperature without pH control
  • Exclude filtration steps to retain undissolved particles

Correct Answer: Ensure equilibrium is reached and use validated analytical quantification (e.g., HPLC)

Q18. Which statement best explains why some Class III drugs may not qualify for a biowaiver despite high solubility?

  • Because Class III drugs are always highly permeable
  • Because absorption is permeability-limited and sensitive to excipient changes that can affect transporters or tight junctions
  • Because solubility is irrelevant for biowaivers
  • Because Class III drugs never dissolve in vitro

Correct Answer: Because absorption is permeability-limited and sensitive to excipient changes that can affect transporters or tight junctions

Q19. Which in vitro permeability assay is cell-free and useful as a high-throughput screen for passive permeability?

  • Caco-2 assay
  • MDCK cell assay
  • PAMPA (Parallel Artificial Membrane Permeability Assay)
  • Human intestinal perfusion

Correct Answer: PAMPA (Parallel Artificial Membrane Permeability Assay)

Q20. In BCS context, why are excipients sometimes critical when granting biowaivers for generics?

  • Excipients never alter drug performance, so they are ignored
  • Certain excipients may affect dissolution, permeability, or transporter activity, altering in vivo absorption
  • Only colorants are reviewed because they change taste
  • Because excipients increase molecular weight of APIs

Correct Answer: Certain excipients may affect dissolution, permeability, or transporter activity, altering in vivo absorption

Q21. Which parameter most directly determines the rate at which a drug appears in systemic circulation (absorption rate)?

  • Tmax only
  • Intrinsic dissolution rate, permeability, and gastric emptying
  • Only the marketed price
  • Color and shape of the tablet

Correct Answer: Intrinsic dissolution rate, permeability, and gastric emptying

Q22. Which process can limit oral bioavailability even if a drug is BCS Class I in vitro?

  • Poor tablet aesthetics
  • Extensive first-pass metabolism or efflux transport
  • High aqueous solubility in all media
  • Low molecular weight

Correct Answer: Extensive first-pass metabolism or efflux transport

Q23. For a weakly basic drug with pKa around 6.5, where in the GI tract would you expect higher solubility?

  • Lower intestine (higher pH) only
  • Stomach (low pH) where the drug is more ionized if basic
  • Solubility is identical throughout the GI tract
  • Colon only because of microbiota

Correct Answer: Stomach (low pH) where the drug is more ionized if basic

Q24. Which of the following is a correct implication of BCS Class IV drugs?

  • They generally pose the least development challenge
  • They present both solubility and permeability challenges, often requiring complex formulation strategies
  • They are ideal candidates for simple immediate-release tablets without modification
  • They always qualify for biowaivers

Correct Answer: They present both solubility and permeability challenges, often requiring complex formulation strategies

Q25. Which regulatory volume is typically used in the dose number calculation for BCS solubility assessment?

  • 1000 mL
  • 250 mL
  • 50 mL
  • 10 L

Correct Answer: 250 mL

Q26. When evaluating permeability using human data, which measurement is commonly used to classify a drug as highly permeable?

  • Fraction of dose excreted unchanged in urine or absolute oral absorption ≥85%
  • Log P less than 0
  • Solubility >100 mg/mL only
  • In vitro Caco-2 Papp below 0.1 ×10^-6 cm/s

Correct Answer: Fraction of dose excreted unchanged in urine or absolute oral absorption ≥85%

Q27. Which formulation approach is most appropriate for improving absorption of a BCS Class III drug?

  • Focus on increasing solubility since permeability is already high
  • Modify formulation to avoid excipient interactions that reduce permeability and ensure rapid dissolution
  • Ignore dissolution testing because solubility is irrelevant
  • Use enteric coating to prevent dissolution in the stomach only

Correct Answer: Modify formulation to avoid excipient interactions that reduce permeability and ensure rapid dissolution

Q28. Which statement about using PAMPA vs Caco-2 assays is accurate?

  • PAMPA models active transport and efflux pumps accurately
  • Caco-2 is cell-based and can indicate transporter-mediated effects; PAMPA models passive permeability only
  • Both assays are identical in mechanism and output
  • PAMPA requires living cells and complex culture conditions

Correct Answer: Caco-2 is cell-based and can indicate transporter-mediated effects; PAMPA models passive permeability only

Q29. How can one experimentally demonstrate a drug’s high permeability for regulatory classification when human data are limited?

  • Rely solely on log P values
  • Use well-validated surrogate data such as mass-balance, human absolute bioavailability, or robust in vitro–in vivo correlation supported by reference compounds
  • Assume high permeability if the drug is crystalline
  • Classify by color and taste tests

Correct Answer: Use well-validated surrogate data such as mass-balance, human absolute bioavailability, or robust in vitro–in vivo correlation supported by reference compounds

Q30. Calculate the dose number (Do) and solubility classification: A drug has a single highest dose of 50 mg and solubility 0.1 mg/mL. Using 250 mL volume, is it considered highly soluble?

  • Do = 0.02; highly soluble
  • Do = 2; not highly soluble
  • Do = 0.5; highly soluble
  • Do = 5; highly soluble

Correct Answer: Do = 2; not highly soluble

Leave a Comment